Imatinib

Drugs and Medications > I > Imatinib

#1 prescribed treatment for Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) and KIT-positive gastrointestinal stromal tumors (KIT+ GIST)
Use of website is governed by the Gleevec is a unique treatment for certain forms of cancer. It works by targeting, and turning off, specific proteins in cancer cells that cause the cancer cells to grow and multiply. Gleevec targets one cancer protein that causes and another cancer protein, called

Drugs and Medications > I > Imatinib

sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148, sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148, sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148, sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148, sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148
All Gleevec Patients, Please Read This! breakthrough in the treatment of CML. Someday, the specific targeting we've proven can work for CML will be used for other cancers. Behind every successful research project, there's a dream of what might be. That inspiration is what sustains you through

Drugs and Medications > I > Imatinib

Gleevec (Imatinib Mesylate) Gleevec is approved to treat a rare cancer called Chronic Myeloid Leukemia (CML), FDA grants Gleevec regular approval as a second line treatment for refractory Chronic Myeloid Leukemia. Date created: January 20, 2004; Updated February 26, 2007 FDA/Center for Drug
waiting for hand_moderation

Drugs and Medications > I > Imatinib

Gleevec seemed to spring up overnight. "Powerful Anti-Cancer Drug Emerges from Basic Biology," trumpeted The New York Times on May 8. Two days later, the Food and Drug Administration (FDA) announced its approval after a record-breaking review period of only two and a half months. With words such as
waiting for hand_moderation

Drugs and Medications > I > Imatinib

Gleevec: Gleevec
Group Information Members: 615 Category: Founded: Jan 14, 2001 Language: English Hear how Yahoo! Groups has changed the lives of others. Check them out and nominate your group. If you are (or were) experiencing problems with Yahoo! groups, visit the A discussion group for Gleevec ® (also

Drugs and Medications > I > Imatinib

Chronic Myelogenous Leukemia Support Home Page.
"Hope, like the gleaming taper’s light, Adorns and cheers our way; And still, as darker grows the night, Emits a brighter ray." — Oliver Goldsmith (1730?–1774) GENERAL INFORMATION ABOUT GLEEVEC/GLIVEC Includes NCI information about Gleevec, plus clinical trial OHSU's Dr. Brian Druker

Drugs and Medications > I > Imatinib

(imatinib mesylate) Tablets for oral use Imatinib is a small molecule kinase inhibitor. Gleevec film-coated tablets contain imatinib mesylate equivalent to 100 mg or 400 mg of imatinib free base. Imatinib mesylate is designated chemically as
waiting for hand_moderation

Drugs and Medications > I > Imatinib

My name is Jim. I like to spend time with my wife Lori and I love to play golf. Welcome to the Life Raft Group The Life Raft Group (LRG) is a 501 (c)(3) non-profit organization providing support, through information, education, and innovative research to patients with a rare cancer called GIST
waiting for hand_moderation

Drugs and Medications > I > Imatinib

Leukaemia drug hailed as major breakthrough STI571 is used to treat chronic myeloid leukaemia (CML) and it targets a genetic abnormality in the leukaemia cells called the Philadelphia chromosome. Unlike other anti-cancer drugs, STI571 selectively switches off signal proteins related to the
waiting for hand_moderation

Drugs and Medications > I > Imatinib

Find out how Glivec has changed the normal course of cancer for patients with Ph+CML and KIT+ GIST by inhibiting the molecular causes of these diseases.
European Summary of Product Characteristics Learn more about Glivec's cutting edge molecularly-targeted treatment mechanism and its application in CML and GIST treatment regimens. Find out how Glivec is transforming the management and treatment of certain cancers, including CML and GIST. The